PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?
PMV Pharmaceuticals Ownership Summary
PMV Pharmaceuticals is owned by 66.68% institutional investors, 2.90% insiders, and 30.42% retail investors. Orbimed advisors is the largest institutional shareholder, holding 12.45% of PMVP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.94% of its assets in PMV Pharmaceuticals shares.
PMVP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | PMV Pharmaceuticals | 66.68% | 2.90% | 30.42% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 6.48M | 12.45% | $6.86M |
| Bml capital management | 5.00M | 9.61% | $5.30M |
| Sio capital management | 3.74M | 7.18% | $3.96M |
| Arrowmark colorado | 3.19M | 6.13% | $3.38M |
| Euclidean capital | 2.63M | 5.05% | $2.79M |
| Alkeon capital management | 2.34M | 4.50% | $2.48M |
| Vanguard group | 2.14M | 4.16% | $3.24M |
| Acadian asset management | 2.07M | 3.97% | $2.19M |
| Blackrock | 1.16M | 2.26% | $1.88M |
| Blackrock funding, inc. /de | 1.14M | 2.19% | $1.21M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 5.00M | 4.01% | $5.30M |
| Sio capital management | 3.74M | 1.51% | $3.96M |
| Euclidean capital | 2.63M | 0.91% | $2.79M |
| Stonepine capital management | 845.97K | 0.88% | $896.73K |
| Aldebaran capital | 515.13K | 0.54% | $546.04K |
| Orbimed advisors | 6.48M | 0.17% | $6.86M |
| Arrowmark colorado | 3.19M | 0.06% | $3.38M |
| Velan capital investment management lp | 35.00K | 0.04% | $38.15K |
| Adar1 capital management | 101.01K | 0.02% | $107.07K |
| Rbf capital | 245.56K | 0.01% | $260.30K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bml capital management | 5.00M | 4.01% | 1.25M |
| Stonepine capital management | 845.97K | 0.88% | 215.78K |
| Assenagon asset management | 263.06K | 0.00% | 148.02K |
| Ubs group | 275.46K | 0.00% | 96.60K |
| Bridgeway capital management | 202.10K | 0.01% | 62.20K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pfm health sciences, lp | - | - | -3.30M |
| Blackrock | 1.16M | - | -1.95M |
| Bank of america corp /de/ | 340.39K | - | -1.03M |
| State street | 145.08K | - | -640.91K |
| Ecor1 capital | - | - | -566.88K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hrt financial lp | 22.44K | 0.00% | 22.44K | $23.00K |
| Deerfield management company, l.p. (series c) | 8.79K | 0.00% | 8.79K | $9.32K |
| Russell investments group | 4.71K | - | 4.71K | $7.63K |
| Macquarie group | 2.08K | - | 2.08K | $3.37K |
| Bnp paribas arbitrage, snc | 763.00 | - | 763.00 | $1.15K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Nisa investment advisors | -105.00 |
| Avion wealth | -299.00 |
| Capital advisors | -322.00 |
| New york state common retirement fund | -341.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 53 | -5.36% | 34,682,029 | -7.07% | 66 | 1.29% | 19 | 90.00% | 20 | -35.48% |
| Mar 31, 2025 | 6 | -91.67% | 13,804,026 | -64.57% | 26 | 0.47% | 2 | -90.48% | 1 | -96.77% |
| Dec 31, 2024 | 23 | -69.33% | 12,134,994 | -68.90% | 23 | 0.41% | 7 | -75.00% | 8 | -72.41% |
| Sep 30, 2024 | 75 | -19.35% | 39,023,924 | -3.62% | 75 | 1.22% | 29 | -35.56% | 29 | -6.45% |
| Jun 30, 2024 | 93 | -7.00% | 40,490,486 | -5.27% | 78 | 1.14% | 45 | -10.00% | 31 | 19.23% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.52M | 2.94% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.49M | 2.82% | -32.61K |
| ArrowMark Small Cap Gro | 1.26M | 2.42% | - |
| Meridian Small Cap Growth Legacy | 1.26M | 2.42% | - |
| ACAP Strategic A | 1.15M | 2.21% | - |
| SQUAD Aguja Opportunities I | 570.00K | 1.08% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 371.20K | 0.70% | -169.15K |
| BlackRock Advantage Small Cap Core Instl | 280.44K | 0.53% | - |
| Goldman Sachs Small Cp Val Insghts Instl | 249.01K | 0.48% | - |
| Fidelity Extended Market Index | 210.94K | 0.41% | -551.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 10, 2025 | ORBIMED ADVISORS LLC | - | Sell | $900.00K |
| Jul 01, 2025 | Ticktin Robert | General Counsel & COO | Sell | $24.65K |
| Jul 01, 2025 | Jalota Deepika | Chief Development Officer | Sell | $35.20K |
| Jul 01, 2025 | Carulli Michael | Chief Financial Officer | Sell | $30.08K |
| Jul 01, 2025 | Mack David Henry | President and CEO | Sell | $62.18K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 2 |
PMVP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools